Clinical outcomes of metastatic non-clear cell renal cell carcinoma: a real-world single-centre experience.
Wu J, Cao CZ, Cui HL, Chen MX, Gao LN, Zheng S, Zhou AP, Guan YY, Bi XG, Shi HZ, Shou JZ.
Ann Med. 2026 Dec;58(1):2613590. doi: 10.1080/07853890.2026.2613590. Epub 2026 Jan 23.
PMID:41578672
Histologic Appearance After Preoperative Radiation Therapy for Soft Tissue Sarcoma: Assessment of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group Response Score.
Schaefer IM, Hornick JL, Barysauskas CM, Raut CP, Patel SA, Royce TJ, Fletcher CDM, Baldini EH.
Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):375-383. doi: 10.1016/j.ijrobp.2017.02.087. Epub 2017 Feb 24.
PMID:28463157
The surgical management of sarcomas of the chest wall: A 13-year single institution experience.
B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
Snuderl M, Kolman OK, Chen YB, Hsu JJ, Ackerman AM, Dal Cin P, Ferry JA, Harris NL, Hasserjian RP, Zukerberg LR, Abramson JS, Hochberg EP, Lee H, Lee AI, Toomey CE, Sohani AR.
Am J Surg Pathol. 2010 Mar;34(3):327-40. doi: 10.1097/PAS.0b013e3181cd3aeb.
PMID:20118770
Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy.
Li YX, Coucke PA, Li JY, Gu DZ, Liu XF, Zhou LQ, Mirimanoff RO, Yu ZH, Huang YR.
Cancer. 1998 Aug 1;83(3):449-56. doi: 10.1002/(sici)1097-0142(19980801)83:3<449::aid-cncr13>3.0.co;2-w.
PMID:9690537
Prognostic factors for renal cell carcinoma with bone metastasis: who are the long-term survivors?
Kume H, Kakutani S, Yamada Y, Shinohara M, Tominaga T, Suzuki M, Fujimura T, Fukuhara H, Enomoto Y, Nishimatsu H, Homma Y.
J Urol. 2011 May;185(5):1611-4. doi: 10.1016/j.juro.2010.12.037. Epub 2011 Mar 17.